Search Legislation

The Food Additives, Food Flavourings and Novel Foods (Authorisations) (Scotland) Regulations 2023

 Help about what version

What Version

  • Latest available (Revised)
  • Original (As made)

Status:

This is the original version (as it was originally made). This item of legislation is currently only available in its original format.

Regulation 7

SCHEDULE 4Amendments to the list of novel foods in the Annex to Commission Implementing Regulation (EU) 2017/2470 for the authorisation of UV-treated baker’s yeast (Saccharomyces cerevisiae) as a novel food

This schedule has no associated Policy Notes

1.  In Table 1 (authorised novel foods), for the entry for UV-treated baker’s yeast (Saccharomyces cerevisiae) substitute the following entry—

UV-treated baker’s yeast (Saccharomyces cerevisiae)Specified food categoryMaximum levels of Vitamin D₂The designation of the novel food on the labelling of food containing it is “vitamin D yeast” or “vitamin D₂ yeast”.The novel food must be inactivated for use in infant formula, follow-on formula, processed cereal-based food and food for special medical purposes.
Yeast- leavened breads and rolls5 µg/100 g
Yeast-leavened fine bakery wares5 µg/100 g
Food supplements as defined in the Food Supplements (Scotland) Regulations 2003(1)In accordance with any relevant requirements contained in regulations applying in relation to Scotland and made under regulation 4 of the Nutrition (Amendment etc.) (EU Exit) Regulations 2019(2)
Pre-packed fresh or dry yeast for home baking

45 µg/100 g for fresh yeast

200 µg/100 g for dry yeast

The designation of the novel food on the labelling of food containing it is “vitamin D yeast” or “vitamin D₂ yeast”.

The labelling of the novel food must bear a statement that the food is only intended for baking and it should not be eaten raw.

The labelling of the novel food must bear instructions for use for the final consumer to ensure a maximum concentration of 5µg/100g of vitamin D₂ in the final home-baked product is not exceeded.

Dishes, including ready-to-eat meals (excluding soups and salads)3 µg/100 gThe designation of the novel food on the labelling of food containing it is “vitamin D yeast” or “vitamin D₂ yeast”.
Soups and salads5 µg/100 g
Fried or extruded cereal, seed or root-based products5 µg/100 g
Infant formula and follow-on formula as defined in Regulation (EU) No. 609/2013(3)In accordance with Regulation (EU) No. 609/2013
Processed cereal-based food as defined in Regulation (EU) No. 609/2013In accordance with Regulation (EU) No. 609/2013
Processed fruit products1.5 µg/100 g
Processed vegetables2 µg/100 g
Bread and similar products5 µg/100 g
Breakfast cereals4 µg/100 g
Pasta, doughs and similar products5 µg/100 g
Other cereal-based products3 µg/100 g

Spices, seasonings, condiments, sauce ingredients, dessert sauces/

toppings

10 µg/100 g
Protein products10 µg/100 g
Cheese2 µg/100 g
Dairy desserts and similar products2 µg/100 g
Fermented milk or fermented cream1.5 µg/100 g
Dairy powders and concentrates25 µg/100 g
Milk-based products, whey and cream0.5 µg/100 g
Meat and dairy analogues2.5 µg/100 g
Total diet replacement for weight control as defined by Regulation (EU) No. 609/20135 µg/100 g
Meal replacement for weight control5 µg/100 g
Food for special medical purposes as defined by Regulation (EU) No. 609/2013In accordance with the particular nutritional requirements of the persons for whom the products are intended

2.  In Table 2 (specifications) for the entry for UV-treated baker’s yeast (Saccharomyces cerevisiae) substitute the following entry—

UV-treated baker’s yeast (Saccharomyces cerevisiae)

Description/Definition

Baker’s yeast (Saccharomyces cerevisiae) is treated with ultraviolet light to induce the conversion of ergosterol to vitamin D₂ (ergocalciferol). Vitamin D₂ content in the yeast concentrate varies between 800,000 - 3,500,000 IU vitamin D/100g (200-875 μg/g). The yeast is inactivated for use in infant formula, follow-on formula, processed cereal-based food, and food for special medical purposes as defined by Regulation (EU) No. 609/2013. The yeast can be active or inactive for use in other foods.

The yeast concentrate is blended with regular baker’s yeast in order not to exceed the maximum level in the pre-packed fresh or dry yeast for home baking.

Tan-coloured, free-flowing granules.

Vitamin D₂

Chemical name: (5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol

Synonym: Ergocalciferol

CAS No.: 50-14-6

Molecular weight: 396.65 g/mol

Microbiological criteria for the yeast concentrate

Coliforms: ≤ 103 CFU/g

Escherichia coli: ≤ 10 CFU/g

Salmonella spp: Absence in 25 g

CFU: Colony Forming Units..

(1)

S.S.I. 2003/278, to which there are amendments not relevant to these Regulations.

(2)

S.I. 2019/651, as relevantly amended by S.I. 2020/1476.

(3)

EUR 2013/609, as relevantly amended by S.I. 2019/651.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

Policy Note

Policy Note sets out a brief statement of the purpose of a Scottish Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Scottish Statutory Instrument accessible to readers who are not legally qualified and accompany any Scottish Statutory Instrument or Draft Scottish Statutory Instrument laid before the Scottish Parliament from July 2012 onwards. Prior to this date these type of notes existed as ‘Executive Notes’ and accompanied Scottish Statutory Instruments from July 2005 until July 2012.

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources